A study introducing iAge and providing mechanistic evidence implicating the chemokine CXCL9 as a key contributor to age-related chronic inflammation
Silverman designs and administers a targeted BPC-157 protocol tailored specifically to affected areas, such as the knee, midfoot, or injured soft tissue structures
For patients who cannot access the injury site with a self-injection, abdominal injection with the understanding that response may be somewhat slower is a practical alternative
The best peptide depends on individual needs, but BPC-157 is known for its healing properties and ability to support recovery
10.1016/S1474-4422(17)30401-5 62 ChicoL.IencoE
Still, persistent, complex, or painless masses, or those accompanied by systemic symptoms, deserve prompt evaluation